Studies of HBK (I) in vitro antibacterial activity of hbk and its therapeutic efficacy on respiratory tract and urinary tract infections by intramuscular injection

Seiichi Aonuma, Reiko Sasaki, Noriko Otani, Kikuo Onuma, Akira Watanabb, Masako Sasaki, Kotaro Oizumi, Kiyoshi Konno, Kazuo Sato

    Research output: Contribution to journalArticlepeer-review

    Abstract

    HBK„ a new aminoglycoside antibiotic, was shown that is possessed a broad antimicrobial spectrum covering Gram-positive cocci and Gram-negative bacilli. Minimal inhibitory concentrations of the agent against each 20 clinical isolates of S. aureus, E. coli, K pneumoniae, S. marcescens, E. cloacae and P. aeruginosa were determined by use of MIC 2000 system. '• At a concentration of 0.39 μg/ml, HBK inhibited all the strains of S. aureus, and at a concentration of 3.13μg/ml, this drug inhibited 85, 100, 80, 80 and 70 per cent of the strains of E.coli, K. pneumoniae, S, marcescens, E. cloacae and P. aeruginosa, respectively. Ten patients suffering from respiratory tract infections and three patients of urinary tract infections received Intramuscularly 50 or 100 mg of HBK twice a day. One patient showed an excellent and nine good clinical response, while one other patient responded only fairly and other two poorly. No undeserable symptoms and signs including deafness due to administration of the drug were observed. In one case slight elevations of serum GOT and slight decrease in white blood cell count were observed, and in another case slight elevation of serum creatinine and slight elevation of serum potassium.

    Original languageEnglish
    Pages (from-to)138-146
    Number of pages9
    JournalChemotherapy
    Volume34
    DOIs
    Publication statusPublished - 1986 Jan 1

    ASJC Scopus subject areas

    • Pharmacology (medical)
    • Infectious Diseases
    • Pharmacology
    • Drug Discovery
    • Oncology

    Fingerprint Dive into the research topics of 'Studies of HBK (I) in vitro antibacterial activity of hbk and its therapeutic efficacy on respiratory tract and urinary tract infections by intramuscular injection'. Together they form a unique fingerprint.

    Cite this